levodopa has been researched along with Complications of Diabetes Mellitus in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Araki, A; Endo, T; Kazuta, T; Terao, S; Torii, R; Yokoi, K | 1 |
| Koya Kutty, S; Mohamed Ibrahim, N; Ramli, R; Shah, SA | 1 |
| Barros, IS; Brito, BS; de Araújo, DF; de Araújo, IT; de Melo Neto, AP; Gondim, Fde A; Horta, WG; Lima, JW; Oliveira, ÍS | 1 |
| Hickey, MA; Morton, AJ; Reynolds, GP | 1 |
| Babakhanov, KhB | 1 |
| Korczyn, A; Salganik, I | 1 |
6 other study(ies) available for levodopa and Complications of Diabetes Mellitus
| Article | Year |
|---|---|
Effectiveness of levodopa treatment for diabetic chorea with reduced striatal accumulation in dopamine transporter SPECT: a case report.
Topics: Aged; Amines; Chorea; Corpus Striatum; Cyclohexanecarboxylic Acids; Diabetes Complications; Dopamine Plasma Membrane Transport Proteins; Drug Therapy, Combination; Dyskinesias; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Hyperglycemic Hyperosmolar Nonketotic Coma; Levodopa; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2017 |
Earlier onset of motor complications in Parkinson's patients with comorbid diabetes mellitus.
Topics: Aged; Antiparkinson Agents; Diabetes Complications; Diabetes Mellitus; Female; Humans; Levodopa; Male; Middle Aged; Motor Activity; Parkinson Disease; Parkinsonian Disorders | 2018 |
Small (autonomic) and large fiber neuropathy in Parkinson disease and parkinsonism.
Topics: Age Factors; Aged; Antiparkinson Agents; Autonomic Nervous System Diseases; Autonomic Pathways; Diabetes Complications; Electromyography; Female; Humans; Levodopa; Male; Middle Aged; Neural Conduction; Neuromuscular Junction; Parkinson Disease; Parkinsonian Disorders; Peripheral Nervous System Diseases; Skin | 2016 |
The role of dopamine in motor symptoms in the R6/2 transgenic mouse model of Huntington's disease.
Topics: Aging; Animals; Behavior, Animal; Brain; Brain Chemistry; Central Nervous System Stimulants; Cocaine; Diabetes Complications; Diabetes Mellitus; Disease Models, Animal; Disease Progression; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Female; Glucose Tolerance Test; Huntington Disease; Levodopa; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Transgenic; Motor Activity; Spatial Behavior; Survival Rate | 2002 |
[Method of determination of somatotropin level in blood plasma with L-dopa loading in patients with diabetes mellitus complicated by microangiopathies].
Topics: Adolescent; Adult; Aged; Diabetes Complications; Diabetes Mellitus; Diabetic Angiopathies; Female; Growth Hormone; Humans; Levodopa; Male; Middle Aged; Radioimmunoassay | 1975 |
Risk factors for dementia in Parkinson's disease.
Topics: Aged; Cardiovascular Diseases; Dementia; Diabetes Complications; Female; Humans; Levodopa; Male; Neurologic Examination; Neuropsychological Tests; Parkinson Disease; Risk Factors; Smoking | 1990 |